У нас вы можете посмотреть бесплатно Symposium Bridging the Gap Between Basic Science and Research in Psychedelic Neuroscience (Part 4) или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
INSIGHT 2023 Replay from the Symposium Track: Symposium – Mapping the Psychedelic Brain: From Molecules to Mind Speakers: Dr. Prateep Beed, Prof. Dr. David Olson, Prof. Dr. Kim Kuypers, Prof. Dr. Robert Malenka, Dr. Torben Ott, Prof. Dr. Dietmar Schmitz (PART 4) Psychedelic research is entering a new era—but the fundamental question remains: What do psychedelics do in the brain? This 3-hour symposium brings together leading voices from basic and clinical neuroscience to explore how psychedelics affect the brain at the molecular, cellular, circuit, and systems levels. Speakers present groundbreaking work from animal and human studies using advanced methods to uncover the neuronal pathways and mechanisms underlying psychedelic effects. From neuroplasticity and receptor dynamics to cognition and behavior, the talks span the full spectrum of psychedelic neuroscience. The session concludes with a panel discussion that reflects on how these findings reshape our understanding of psychedelics, their potential as therapeutics, and the directions future research must take to bridge the remaining gaps in our knowledge. This is only one of dozens of excellent contributions to the INSIGHT 2023 conference. Get full access to over 50 recordings of the latest discoveries in psychedelic science and therapy – from talks to panel discussions and whole symposia – with the INSIGHT 2023 Replays bundle for only 29 EUR: https://mind-foundation.org/product/i... Each purchase supports the MIND Foundation's mission to promote human development by bridging science and experience, and to make psychedelic therapies a reality in the public health care system.